
Switching to a ‘nuke‐sparing’ raltegravir/atazanavir combination: an individualised approach
Author(s) -
Grant A,
Kamuntu Y,
Read P,
Kulasegaram R
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p33
Subject(s) - raltegravir , atazanavir , medicine , antiretroviral therapy , integrase inhibitor , human immunodeficiency virus (hiv) , virology , intensive care medicine , pharmacology , viral load
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK